Matches in SemOpenAlex for { <https://semopenalex.org/work/W2145536576> ?p ?o ?g. }
- W2145536576 endingPage "215" @default.
- W2145536576 startingPage "210" @default.
- W2145536576 abstract "Objective: Primary graft dysfunction caused by ischemia–reperfusion injury is one of the most frequent causes of early morbidity and death after lung transplantation. We hypothesized that the perioperative management with aprotinin decreases the incidence of allograft reperfusion injury and dysfunction after clinical lung transplantation. Methods: Lung transplant databases of two transplant centers were used to investigate the incidence of severe post-transplant reperfusion injury (PTRI). We examined data of 142 patients who underwent either single lung (81) or bilateral sequential lung (61) transplantation for COPD, idiopathic pulmonary fibrosis, cystic fibrosis, and miscellaneous lung disorders between 1997 and 2000. Thirty patients were excluded due to heart–lung transplantation or lung transplantation for Eisenmenger's disease, re-transplantation, rejection, or deviation from the standardized triple immunosuppression protocol. The data of remaining 112 patients (control group, 64% single lung, 36% sequential bilateral lung transplants) were compared to the prospectively collected data of 59 lung transplant patients over the last 5 years. All of these 59 patients were managed perioperatively with aprotinin infusion. In addition, Euro-Collins-aprotinin procurement solution (Apt-EC group) was used for 50 donor lungs (58% single lung, 42% sequential bilateral lung transplants). Aprotinin in combination with low-potassium dextran (LPD) flush solution (Apt-LPD group) was used for the procurement of 34 lungs (59% single lung, 41% sequential bilateral lung transplants). The International Society of Heart and Lung Transplantation (ISHLT) grade III injury score was used for the diagnosis of severe PTRI, which is based on a PaO2–FIO2 ratio of less than 200 mmHg. Results: Severe reperfusion injury grade III was observed in 18% of the control group. ECMO support was required in 25% of these patients. The associated mortality rate was 40%. Correlating factors for PTRI were donor age greater than 35 years (45%, p = 0.01, mean age 38 ± 8) and recipient pulmonary artery systolic pressure greater than 60 mmHg (48%, p ≪ 0.05). Lung graft ischemic times (231 ± 14 min) and intraoperative techniques (cardiopulmonary bypass in 12%) were not associated with negative outcomes. Despite longer ischemic times (258 ± 36 min and 317 ± 85 min, respectively) and older donors (42 ± 12 years and 46 ± 12 years, respectively) in the aprotinin patient groups (Apt-EC and Apt-LPD group), the incidence of PTRI was markedly lower (6% and 9%, respectively). There was no mortality in the Apt-EC group and one patient died in the Apt-LPD group due to PTRI-induced graft failure. Conclusions: Severe PTRI increased short-term morbidity and mortality. The incidence of reperfusion injury was not dependent upon the duration of donor organ ischemia. The use of aprotinin in the perioperative patient management in lung transplantation had strong beneficial effects on the patient outcomes and decreased the incidence of post-transplant ischemia–reperfusion injury significantly." @default.
- W2145536576 created "2016-06-24" @default.
- W2145536576 creator A5015651665 @default.
- W2145536576 creator A5027502266 @default.
- W2145536576 creator A5033250422 @default.
- W2145536576 creator A5048103148 @default.
- W2145536576 creator A5056385986 @default.
- W2145536576 creator A5083907006 @default.
- W2145536576 creator A5086278880 @default.
- W2145536576 date "2006-02-01" @default.
- W2145536576 modified "2023-10-03" @default.
- W2145536576 title "Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation☆" @default.
- W2145536576 cites W1971689909 @default.
- W2145536576 cites W1976548281 @default.
- W2145536576 cites W1979021516 @default.
- W2145536576 cites W1991624856 @default.
- W2145536576 cites W2001108522 @default.
- W2145536576 cites W2016523110 @default.
- W2145536576 cites W2020675157 @default.
- W2145536576 cites W2021165009 @default.
- W2145536576 cites W2034727322 @default.
- W2145536576 cites W2038290324 @default.
- W2145536576 cites W2039617170 @default.
- W2145536576 cites W2042559377 @default.
- W2145536576 cites W2045388173 @default.
- W2145536576 cites W2059656604 @default.
- W2145536576 cites W2063701339 @default.
- W2145536576 cites W2105366913 @default.
- W2145536576 cites W2134371457 @default.
- W2145536576 cites W2144391693 @default.
- W2145536576 cites W2145330473 @default.
- W2145536576 cites W2150397968 @default.
- W2145536576 cites W2154086632 @default.
- W2145536576 cites W2419173838 @default.
- W2145536576 cites W2522810121 @default.
- W2145536576 doi "https://doi.org/10.1016/j.ejcts.2005.12.001" @default.
- W2145536576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16386921" @default.
- W2145536576 hasPublicationYear "2006" @default.
- W2145536576 type Work @default.
- W2145536576 sameAs 2145536576 @default.
- W2145536576 citedByCount "31" @default.
- W2145536576 countsByYear W21455365762012 @default.
- W2145536576 countsByYear W21455365762014 @default.
- W2145536576 countsByYear W21455365762015 @default.
- W2145536576 countsByYear W21455365762018 @default.
- W2145536576 countsByYear W21455365762019 @default.
- W2145536576 countsByYear W21455365762020 @default.
- W2145536576 countsByYear W21455365762021 @default.
- W2145536576 countsByYear W21455365762023 @default.
- W2145536576 crossrefType "journal-article" @default.
- W2145536576 hasAuthorship W2145536576A5015651665 @default.
- W2145536576 hasAuthorship W2145536576A5027502266 @default.
- W2145536576 hasAuthorship W2145536576A5033250422 @default.
- W2145536576 hasAuthorship W2145536576A5048103148 @default.
- W2145536576 hasAuthorship W2145536576A5056385986 @default.
- W2145536576 hasAuthorship W2145536576A5083907006 @default.
- W2145536576 hasAuthorship W2145536576A5086278880 @default.
- W2145536576 hasBestOaLocation W21455365761 @default.
- W2145536576 hasConcept C126322002 @default.
- W2145536576 hasConcept C141071460 @default.
- W2145536576 hasConcept C2777714996 @default.
- W2145536576 hasConcept C2778341716 @default.
- W2145536576 hasConcept C2780799893 @default.
- W2145536576 hasConcept C2781244666 @default.
- W2145536576 hasConcept C2781448352 @default.
- W2145536576 hasConcept C2911091166 @default.
- W2145536576 hasConcept C31174226 @default.
- W2145536576 hasConcept C42219234 @default.
- W2145536576 hasConcept C71924100 @default.
- W2145536576 hasConceptScore W2145536576C126322002 @default.
- W2145536576 hasConceptScore W2145536576C141071460 @default.
- W2145536576 hasConceptScore W2145536576C2777714996 @default.
- W2145536576 hasConceptScore W2145536576C2778341716 @default.
- W2145536576 hasConceptScore W2145536576C2780799893 @default.
- W2145536576 hasConceptScore W2145536576C2781244666 @default.
- W2145536576 hasConceptScore W2145536576C2781448352 @default.
- W2145536576 hasConceptScore W2145536576C2911091166 @default.
- W2145536576 hasConceptScore W2145536576C31174226 @default.
- W2145536576 hasConceptScore W2145536576C42219234 @default.
- W2145536576 hasConceptScore W2145536576C71924100 @default.
- W2145536576 hasIssue "2" @default.
- W2145536576 hasLocation W21455365761 @default.
- W2145536576 hasLocation W21455365762 @default.
- W2145536576 hasOpenAccess W2145536576 @default.
- W2145536576 hasPrimaryLocation W21455365761 @default.
- W2145536576 hasRelatedWork W1966064185 @default.
- W2145536576 hasRelatedWork W2025562991 @default.
- W2145536576 hasRelatedWork W2091369377 @default.
- W2145536576 hasRelatedWork W2318104575 @default.
- W2145536576 hasRelatedWork W2388539772 @default.
- W2145536576 hasRelatedWork W2412261089 @default.
- W2145536576 hasRelatedWork W2551354873 @default.
- W2145536576 hasRelatedWork W2794339623 @default.
- W2145536576 hasRelatedWork W4206438212 @default.
- W2145536576 hasRelatedWork W2600720537 @default.
- W2145536576 hasVolume "29" @default.
- W2145536576 isParatext "false" @default.
- W2145536576 isRetracted "false" @default.